Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells
Advanced glycation end‐product (AGE) is important in the pathogenesis of diabetic nephropathy (DN), and captopril (an angiotensin converting enzyme inhibitor) is effective in treating this disorder. We have shown that the Janus kinase (JAK)/signal transducers and activators of transcription (STAT) c...
Gespeichert in:
Veröffentlicht in: | Journal of cellular biochemistry 2001-01, Vol.81 (1), p.102-113 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 113 |
---|---|
container_issue | 1 |
container_start_page | 102 |
container_title | Journal of cellular biochemistry |
container_volume | 81 |
creator | Huang, Jau-Shyang Guh, Jinn-Yuh Chen, Hung-Chun Hung, Wen-Chun Lai, Yung-Hsiung Chuang, Lea-Yea |
description | Advanced glycation end‐product (AGE) is important in the pathogenesis of diabetic nephropathy (DN), and captopril (an angiotensin converting enzyme inhibitor) is effective in treating this disorder. We have shown that the Janus kinase (JAK)/signal transducers and activators of transcription (STAT) cascade is responsible for AGE‐induced mitogenesis in NRK‐49F (normal rat kidney fibroblast) cells, but its role in renal fibrosis in DN remains unknown. Therefore, we have sought to determine whether JAK/STAT is involved in AGE‐regulated collagen production in NRK‐49F cells. We found that AGE time (1–7 days) and dose (10–200 μg/ml)‐dependently increased collagen production in these cells. Additionally, AGE increased RAGE (receptor for AGE) protein expression. AGE‐induced RAGE expression was dose‐dependently inhibited by antisense RAGE oligodeoxynucleotide (ODN) and captopril. AGE‐induced type I collagen production and JAK2‐STAT1/STAT3 activation were decreased by AG‐490 (a specific JAK2 inhibitor), antisense RAGE ODN and captopril. Meanwhile, STAT1 and STAT3 decoy ODNs also suppressed the induction of collagen by AGE. We concluded that RAGE and the JAK2‐STAT1/STAT3 pathway were involved in AGE‐induced collagen production in NRK‐49F cells. Furthermore, captopril was found to reverse AGE‐induced collagen production, probably by attenuating RAGE expression and JAK2‐STAT1/STAT3 activities. J. Cell. Biochem. 81:102–113, 2001. © 2001 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/1097-4644(20010401)81:1<102::AID-JCB1027>3.0.CO;2-Y |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70611811</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70611811</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4677-27d9f7cafefbf79b88851b9479e7161b212bd2e1478d377ee974a6457542ca853</originalsourceid><addsrcrecordid>eNqVkd9u0zAUxiMEYmXwCshXaLtw5-O4cdIhpJCtZX-0Sl1RNW6OHMfpAmnSxSmjj8Eb46jZuOEGWZYt-zu_7-h8nncKbAiM8RNgkaQiEOKIMwZMMDgOYQwfgfHxOL44o5fJZ3eXn_whGyazU07vXniD56qX3oBJn1HuAz_w3lj7nTEWRT5_7R0AQNgBB97veV0aUuekMdps2rohudsq-6kqbTKyKndatUVdEVNldNPU2Va35GgeT8-Piaoy0t4bchlfndwu4gW1xapSZVGtyEa1949qR4qKOCktKlfncLouS7UyFelJHdhJbuZXVEQTok1Z2rfeq1yV1rzrz0Pv6-R8kXyh17PpRRJfUy0CKSmXWZRLrXKTp7mM0jAMR5BGQkZGQgApB55m3ICQYeZLaUwkhQrESI4E1yoc-Yfehz3X9fKwNbbFdWG7DlRl6q1FyQI3JQAnvN0LdVNb25gcN02xVs0OgWGXFHYzx27m-JQUhoBuuT90SWGfFPrIMJkhxztHfd_bb9O1yf4y-2icYLkXPBal2f2X578tn54cme7JhW3Nr2eyan5gIH05wuXNFBPGv03EMsDE_wMfMroS</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70611811</pqid></control><display><type>article</type><title>Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Huang, Jau-Shyang ; Guh, Jinn-Yuh ; Chen, Hung-Chun ; Hung, Wen-Chun ; Lai, Yung-Hsiung ; Chuang, Lea-Yea</creator><creatorcontrib>Huang, Jau-Shyang ; Guh, Jinn-Yuh ; Chen, Hung-Chun ; Hung, Wen-Chun ; Lai, Yung-Hsiung ; Chuang, Lea-Yea</creatorcontrib><description>Advanced glycation end‐product (AGE) is important in the pathogenesis of diabetic nephropathy (DN), and captopril (an angiotensin converting enzyme inhibitor) is effective in treating this disorder. We have shown that the Janus kinase (JAK)/signal transducers and activators of transcription (STAT) cascade is responsible for AGE‐induced mitogenesis in NRK‐49F (normal rat kidney fibroblast) cells, but its role in renal fibrosis in DN remains unknown. Therefore, we have sought to determine whether JAK/STAT is involved in AGE‐regulated collagen production in NRK‐49F cells. We found that AGE time (1–7 days) and dose (10–200 μg/ml)‐dependently increased collagen production in these cells. Additionally, AGE increased RAGE (receptor for AGE) protein expression. AGE‐induced RAGE expression was dose‐dependently inhibited by antisense RAGE oligodeoxynucleotide (ODN) and captopril. AGE‐induced type I collagen production and JAK2‐STAT1/STAT3 activation were decreased by AG‐490 (a specific JAK2 inhibitor), antisense RAGE ODN and captopril. Meanwhile, STAT1 and STAT3 decoy ODNs also suppressed the induction of collagen by AGE. We concluded that RAGE and the JAK2‐STAT1/STAT3 pathway were involved in AGE‐induced collagen production in NRK‐49F cells. Furthermore, captopril was found to reverse AGE‐induced collagen production, probably by attenuating RAGE expression and JAK2‐STAT1/STAT3 activities. J. Cell. Biochem. 81:102–113, 2001. © 2001 Wiley‐Liss, Inc.</description><identifier>ISSN: 0730-2312</identifier><identifier>EISSN: 1097-4644</identifier><identifier>DOI: 10.1002/1097-4644(20010401)81:1<102::AID-JCB1027>3.0.CO;2-Y</identifier><identifier>PMID: 11180401</identifier><language>eng</language><publisher>New York: John Wiley & Sons, Inc</publisher><subject>advanced glycation end-product ; Base Sequence ; captopril ; Captopril - pharmacology ; Cell Line ; Collagen - biosynthesis ; diabetic nephropathy ; DNA Primers ; DNA-Binding Proteins - metabolism ; Dose-Response Relationship, Drug ; Down-Regulation - drug effects ; Glycation End Products, Advanced ; Janus Kinase 2 ; Kinetics ; oligodeoxynucleotide ; Oligonucleotides, Antisense - pharmacology ; Phosphorylation ; Protein-Tyrosine Kinases - metabolism ; Proto-Oncogene Proteins ; Receptor for Advanced Glycation End Products ; Receptors, Immunologic - genetics ; Receptors, Immunologic - metabolism ; Signal Transduction ; STAT1 Transcription Factor ; STAT3 Transcription Factor ; Trans-Activators - metabolism ; Tyrosine - metabolism ; tyrosine phosphorylation ; Tyrphostins - pharmacology</subject><ispartof>Journal of cellular biochemistry, 2001-01, Vol.81 (1), p.102-113</ispartof><rights>Copyright © 2001 Wiley‐Liss, Inc.</rights><rights>Copyright 2001 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4677-27d9f7cafefbf79b88851b9479e7161b212bd2e1478d377ee974a6457542ca853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F1097-4644%2820010401%2981%3A1%3C102%3A%3AAID-JCB1027%3E3.0.CO%3B2-Y$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F1097-4644%2820010401%2981%3A1%3C102%3A%3AAID-JCB1027%3E3.0.CO%3B2-Y$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27922,27923,45572,45573</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11180401$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huang, Jau-Shyang</creatorcontrib><creatorcontrib>Guh, Jinn-Yuh</creatorcontrib><creatorcontrib>Chen, Hung-Chun</creatorcontrib><creatorcontrib>Hung, Wen-Chun</creatorcontrib><creatorcontrib>Lai, Yung-Hsiung</creatorcontrib><creatorcontrib>Chuang, Lea-Yea</creatorcontrib><title>Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells</title><title>Journal of cellular biochemistry</title><addtitle>J. Cell. Biochem</addtitle><description>Advanced glycation end‐product (AGE) is important in the pathogenesis of diabetic nephropathy (DN), and captopril (an angiotensin converting enzyme inhibitor) is effective in treating this disorder. We have shown that the Janus kinase (JAK)/signal transducers and activators of transcription (STAT) cascade is responsible for AGE‐induced mitogenesis in NRK‐49F (normal rat kidney fibroblast) cells, but its role in renal fibrosis in DN remains unknown. Therefore, we have sought to determine whether JAK/STAT is involved in AGE‐regulated collagen production in NRK‐49F cells. We found that AGE time (1–7 days) and dose (10–200 μg/ml)‐dependently increased collagen production in these cells. Additionally, AGE increased RAGE (receptor for AGE) protein expression. AGE‐induced RAGE expression was dose‐dependently inhibited by antisense RAGE oligodeoxynucleotide (ODN) and captopril. AGE‐induced type I collagen production and JAK2‐STAT1/STAT3 activation were decreased by AG‐490 (a specific JAK2 inhibitor), antisense RAGE ODN and captopril. Meanwhile, STAT1 and STAT3 decoy ODNs also suppressed the induction of collagen by AGE. We concluded that RAGE and the JAK2‐STAT1/STAT3 pathway were involved in AGE‐induced collagen production in NRK‐49F cells. Furthermore, captopril was found to reverse AGE‐induced collagen production, probably by attenuating RAGE expression and JAK2‐STAT1/STAT3 activities. J. Cell. Biochem. 81:102–113, 2001. © 2001 Wiley‐Liss, Inc.</description><subject>advanced glycation end-product</subject><subject>Base Sequence</subject><subject>captopril</subject><subject>Captopril - pharmacology</subject><subject>Cell Line</subject><subject>Collagen - biosynthesis</subject><subject>diabetic nephropathy</subject><subject>DNA Primers</subject><subject>DNA-Binding Proteins - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Down-Regulation - drug effects</subject><subject>Glycation End Products, Advanced</subject><subject>Janus Kinase 2</subject><subject>Kinetics</subject><subject>oligodeoxynucleotide</subject><subject>Oligonucleotides, Antisense - pharmacology</subject><subject>Phosphorylation</subject><subject>Protein-Tyrosine Kinases - metabolism</subject><subject>Proto-Oncogene Proteins</subject><subject>Receptor for Advanced Glycation End Products</subject><subject>Receptors, Immunologic - genetics</subject><subject>Receptors, Immunologic - metabolism</subject><subject>Signal Transduction</subject><subject>STAT1 Transcription Factor</subject><subject>STAT3 Transcription Factor</subject><subject>Trans-Activators - metabolism</subject><subject>Tyrosine - metabolism</subject><subject>tyrosine phosphorylation</subject><subject>Tyrphostins - pharmacology</subject><issn>0730-2312</issn><issn>1097-4644</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkd9u0zAUxiMEYmXwCshXaLtw5-O4cdIhpJCtZX-0Sl1RNW6OHMfpAmnSxSmjj8Eb46jZuOEGWZYt-zu_7-h8nncKbAiM8RNgkaQiEOKIMwZMMDgOYQwfgfHxOL44o5fJZ3eXn_whGyazU07vXniD56qX3oBJn1HuAz_w3lj7nTEWRT5_7R0AQNgBB97veV0aUuekMdps2rohudsq-6kqbTKyKndatUVdEVNldNPU2Va35GgeT8-Piaoy0t4bchlfndwu4gW1xapSZVGtyEa1949qR4qKOCktKlfncLouS7UyFelJHdhJbuZXVEQTok1Z2rfeq1yV1rzrz0Pv6-R8kXyh17PpRRJfUy0CKSmXWZRLrXKTp7mM0jAMR5BGQkZGQgApB55m3ICQYeZLaUwkhQrESI4E1yoc-Yfehz3X9fKwNbbFdWG7DlRl6q1FyQI3JQAnvN0LdVNb25gcN02xVs0OgWGXFHYzx27m-JQUhoBuuT90SWGfFPrIMJkhxztHfd_bb9O1yf4y-2icYLkXPBal2f2X578tn54cme7JhW3Nr2eyan5gIH05wuXNFBPGv03EMsDE_wMfMroS</recordid><startdate>20010101</startdate><enddate>20010101</enddate><creator>Huang, Jau-Shyang</creator><creator>Guh, Jinn-Yuh</creator><creator>Chen, Hung-Chun</creator><creator>Hung, Wen-Chun</creator><creator>Lai, Yung-Hsiung</creator><creator>Chuang, Lea-Yea</creator><general>John Wiley & Sons, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010101</creationdate><title>Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells</title><author>Huang, Jau-Shyang ; Guh, Jinn-Yuh ; Chen, Hung-Chun ; Hung, Wen-Chun ; Lai, Yung-Hsiung ; Chuang, Lea-Yea</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4677-27d9f7cafefbf79b88851b9479e7161b212bd2e1478d377ee974a6457542ca853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>advanced glycation end-product</topic><topic>Base Sequence</topic><topic>captopril</topic><topic>Captopril - pharmacology</topic><topic>Cell Line</topic><topic>Collagen - biosynthesis</topic><topic>diabetic nephropathy</topic><topic>DNA Primers</topic><topic>DNA-Binding Proteins - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Down-Regulation - drug effects</topic><topic>Glycation End Products, Advanced</topic><topic>Janus Kinase 2</topic><topic>Kinetics</topic><topic>oligodeoxynucleotide</topic><topic>Oligonucleotides, Antisense - pharmacology</topic><topic>Phosphorylation</topic><topic>Protein-Tyrosine Kinases - metabolism</topic><topic>Proto-Oncogene Proteins</topic><topic>Receptor for Advanced Glycation End Products</topic><topic>Receptors, Immunologic - genetics</topic><topic>Receptors, Immunologic - metabolism</topic><topic>Signal Transduction</topic><topic>STAT1 Transcription Factor</topic><topic>STAT3 Transcription Factor</topic><topic>Trans-Activators - metabolism</topic><topic>Tyrosine - metabolism</topic><topic>tyrosine phosphorylation</topic><topic>Tyrphostins - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huang, Jau-Shyang</creatorcontrib><creatorcontrib>Guh, Jinn-Yuh</creatorcontrib><creatorcontrib>Chen, Hung-Chun</creatorcontrib><creatorcontrib>Hung, Wen-Chun</creatorcontrib><creatorcontrib>Lai, Yung-Hsiung</creatorcontrib><creatorcontrib>Chuang, Lea-Yea</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huang, Jau-Shyang</au><au>Guh, Jinn-Yuh</au><au>Chen, Hung-Chun</au><au>Hung, Wen-Chun</au><au>Lai, Yung-Hsiung</au><au>Chuang, Lea-Yea</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells</atitle><jtitle>Journal of cellular biochemistry</jtitle><addtitle>J. Cell. Biochem</addtitle><date>2001-01-01</date><risdate>2001</risdate><volume>81</volume><issue>1</issue><spage>102</spage><epage>113</epage><pages>102-113</pages><issn>0730-2312</issn><eissn>1097-4644</eissn><abstract>Advanced glycation end‐product (AGE) is important in the pathogenesis of diabetic nephropathy (DN), and captopril (an angiotensin converting enzyme inhibitor) is effective in treating this disorder. We have shown that the Janus kinase (JAK)/signal transducers and activators of transcription (STAT) cascade is responsible for AGE‐induced mitogenesis in NRK‐49F (normal rat kidney fibroblast) cells, but its role in renal fibrosis in DN remains unknown. Therefore, we have sought to determine whether JAK/STAT is involved in AGE‐regulated collagen production in NRK‐49F cells. We found that AGE time (1–7 days) and dose (10–200 μg/ml)‐dependently increased collagen production in these cells. Additionally, AGE increased RAGE (receptor for AGE) protein expression. AGE‐induced RAGE expression was dose‐dependently inhibited by antisense RAGE oligodeoxynucleotide (ODN) and captopril. AGE‐induced type I collagen production and JAK2‐STAT1/STAT3 activation were decreased by AG‐490 (a specific JAK2 inhibitor), antisense RAGE ODN and captopril. Meanwhile, STAT1 and STAT3 decoy ODNs also suppressed the induction of collagen by AGE. We concluded that RAGE and the JAK2‐STAT1/STAT3 pathway were involved in AGE‐induced collagen production in NRK‐49F cells. Furthermore, captopril was found to reverse AGE‐induced collagen production, probably by attenuating RAGE expression and JAK2‐STAT1/STAT3 activities. J. Cell. Biochem. 81:102–113, 2001. © 2001 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>John Wiley & Sons, Inc</pub><pmid>11180401</pmid><doi>10.1002/1097-4644(20010401)81:1<102::AID-JCB1027>3.0.CO;2-Y</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0730-2312 |
ispartof | Journal of cellular biochemistry, 2001-01, Vol.81 (1), p.102-113 |
issn | 0730-2312 1097-4644 |
language | eng |
recordid | cdi_proquest_miscellaneous_70611811 |
source | MEDLINE; Wiley Online Library All Journals |
subjects | advanced glycation end-product Base Sequence captopril Captopril - pharmacology Cell Line Collagen - biosynthesis diabetic nephropathy DNA Primers DNA-Binding Proteins - metabolism Dose-Response Relationship, Drug Down-Regulation - drug effects Glycation End Products, Advanced Janus Kinase 2 Kinetics oligodeoxynucleotide Oligonucleotides, Antisense - pharmacology Phosphorylation Protein-Tyrosine Kinases - metabolism Proto-Oncogene Proteins Receptor for Advanced Glycation End Products Receptors, Immunologic - genetics Receptors, Immunologic - metabolism Signal Transduction STAT1 Transcription Factor STAT3 Transcription Factor Trans-Activators - metabolism Tyrosine - metabolism tyrosine phosphorylation Tyrphostins - pharmacology |
title | Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T17%3A56%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20receptor%20for%20advanced%20glycation%20end-product%20(RAGE)%20and%20the%20JAK/STAT-signaling%20pathway%20in%20AGE-induced%20collagen%20production%20in%20NRK-49F%20cells&rft.jtitle=Journal%20of%20cellular%20biochemistry&rft.au=Huang,%20Jau-Shyang&rft.date=2001-01-01&rft.volume=81&rft.issue=1&rft.spage=102&rft.epage=113&rft.pages=102-113&rft.issn=0730-2312&rft.eissn=1097-4644&rft_id=info:doi/10.1002/1097-4644(20010401)81:1%3C102::AID-JCB1027%3E3.0.CO;2-Y&rft_dat=%3Cproquest_cross%3E70611811%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70611811&rft_id=info:pmid/11180401&rfr_iscdi=true |